About Coriell Life Sciences
Coriell Life Sciences is a company based in Camden (United States) founded in 2013 was acquired by InformedDNA in March 2025.. Coriell Life Sciences has raised $10.07 million across 2 funding rounds from investors including InformedDNA. Coriell Life Sciences offers products and services including Corigen and Research Analysis. Coriell Life Sciences operates in a competitive market with competitors including Omega Therapeutics, BAMF Health, InpharmD, BiomeSense and LifeOmic, among others.
- Headquarter Camden, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$10.07 M (USD)
in 2 rounds
-
Latest Funding Round
$9.47 M (USD), Series A
May 06, 2019
- Investors
-
Employee Count
Employee Count
-
Acquired by
InformedDNA
(Mar 19, 2025)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Coriell Life Sciences
Coriell Life Sciences offers a comprehensive portfolio of products and services, including Corigen and Research Analysis. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Improves medication efficacy through DNA testing and reduces healthcare costs.
Offers analysis for conditions like women's health and infections via genetic methods.
Unlock access to complete
Unlock access to complete
Funding Insights of Coriell Life Sciences
Coriell Life Sciences has successfully raised a total of $10.07M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $9.47 million completed in May 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series A — $9.5M
-
First Round
First Round
(19 Jul 2016)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2019 | Amount | Series A - Coriell Life Sciences | Valuation |
investors |
|
| Jul, 2016 | Amount | Seed - Coriell Life Sciences | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Coriell Life Sciences
Coriell Life Sciences has secured backing from 1 investor. Prominent investors backing the company include InformedDNA. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Network of genetics experts provided to assist patients and providers.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Coriell Life Sciences
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Coriell Life Sciences
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Coriell Life Sciences Comparisons
Competitors of Coriell Life Sciences
Coriell Life Sciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Omega Therapeutics, BAMF Health, InpharmD, BiomeSense and LifeOmic, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Platform for human genome study is provided for precision medicine.
|
|
| domain | founded_year | HQ Location |
AI-enabled molecular imaging and theranostics for disease diagnostics are developed.
|
|
| domain | founded_year | HQ Location |
Evidence-based drug information is provided to healthcare providers online.
|
|
| domain | founded_year | HQ Location |
AI-enabled platform for microbiome data generation and analysis is developed.
|
|
| domain | founded_year | HQ Location |
Storage, management and analysis of omic data for health applications
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Coriell Life Sciences
Frequently Asked Questions about Coriell Life Sciences
When was Coriell Life Sciences founded?
Coriell Life Sciences was founded in 2013 and raised its 1st funding round 3 years after it was founded.
Where is Coriell Life Sciences located?
Coriell Life Sciences is headquartered in Camden, United States.
Is Coriell Life Sciences a funded company?
Coriell Life Sciences is a funded company, having raised a total of $10.07M across 2 funding rounds to date. The company's 1st funding round was a Seed of $605K, raised on Jul 19, 2016.
What does Coriell Life Sciences do?
Coriell Life Sciences was founded in 2013 in Camden, United States, within the precision medicine sector. Platform technologies are utilized by clinicians to order genomic sequencing, obtain expert interpretations, and maintain secure storage of genomic data. The flagship product, GeneDose, is applied to buccal swabs from patients to forecast drug pharmacokinetics, metabolism, and potential adverse effects. Therapeutic solutions are provided across pain management, cardiology, gastroenterology, neurology, psychiatry, and additional fields.
Who are the top competitors of Coriell Life Sciences?
Coriell Life Sciences's top competitors include Omega Therapeutics, CueZen and BAMF Health.
What products or services does Coriell Life Sciences offer?
Coriell Life Sciences offers Corigen and Research Analysis.
Who are Coriell Life Sciences's investors?
Coriell Life Sciences has 1 investor. Key investors include InformedDNA.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.